Global Pathogen Reduction Systems Market to Grow with a CAGR of 8.0% through 2028

Increasing Awareness and Emphasis on Infection Control and Rising Incidence of Hospital Associated Infections is expected to drive the Global Pathogen Reduction Systems Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Global Pathogen Reduction Systems Market - Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Pathogen Reduction Systems Market stood at USD 719.06 million in 2022 and is anticipated to grow with a CAGR of 8.0% in the forecast period, 2024-2028. The global market for pathogen reduction systems is primarily driven by the increase in infectious diseases and the growing public awareness of the importance of safe blood transfusions. Every year, millions of lives are saved through blood transfusion, which is considered a fundamental pillar of the modern healthcare system. However, many patients in low- and middle-income countries still face challenges in accessing timely and secure blood supplies.

Market limitations include concerns about potential influence or damage to blood cells, as well as the production of harmful chemical agents during pathogen reduction treatment. Additionally, fair remuneration remains a significant consideration. The evaluation of these innovative technologies will likely be greatly influenced by ongoing research and development efforts. The expansion of blood transfusion diagnostics is expected to create more opportunities, as well as advancements in preventing and eliminating bacterial infiltration in the blood recipient's body, thus opening doors for the global pathogen reduction system market.

Despite numerous proactive measures taken to ensure blood safety, such as strict donor screening, the implementation of new exclusion criteria, and transfusion hemovigilance, there is still a risk of transfusion-transmitted infections (TTI). Pathogen reduction systems have been developed to safeguard the blood supply by inactivating or removing viruses, bacteria, fungi, or protozoan pathogens. These systems utilize photochemical processes to render bacteria and viruses inactive, minimizing the risk of infection in blood products. Various physical, chemical, or photochemical techniques have been devised to inactivate or reduce pathogens and enhance the safety of the blood supply. Maintaining platelet activity, crucial for post-transfusion survival and recovery, is a key aspect of photochemical therapy, which was specifically developed for platelet therapy.

While the risk factor in pathogen reduction systems is significantly lower, caution must be exercised when using chemicals in the pathogen reduction process due to their multiple sites of action. For instance, cross-linking of lipids in organelles and cell membranes can occur. Protein-protein interactions between pathogen reduction systems and proteins can lead to malfunctions in cellular signal transduction, respiratory pathway deficits, or structural abnormalities. Chemicals attaching to nucleic acids or intercalating nucleic acid chains can cause errors in transcription, translation, or replication. The limitations in the market have been significant, with concerns about the potential influence or damage to blood cells and the production of harmful chemical agents during pathogen reduction treatment. Fair remuneration is also a concern. Ongoing research and development will greatly influence the assessment of these novel technologies. It is predicted that an increase in blood transfusion diagnostics will create more opportunities. Furthermore, advancements in technology to prevent and eliminate bacterial infiltration in the blood recipients' bodies will open up global opportunities in the pathogen reduction system market.

The risk associated with these systems is minimal, which is why medical professionals widely adopt them for platelet and plasma reduction from blood donors. The market is driven by the increasing prevalence of infectious diseases, rising public awareness of better healthcare facilities, and the adoption of advanced technologies that result in improved and more effective pathogen reduction systems.

Pathogen reduction systems are utilized to deactivate viruses and bacteria that may contaminate blood products. These advanced products utilize ultraviolet rays in the presence of a photosensitizer to act as a pathogen inactivator. They are essential in the management of blood transfusion and pathogen inactivation.

 

Browse over 26 market data Figures spread through 91 Pages and an in-depth TOC on "Global Pathogen Reduction Systems Market.”

 

The Global Pathogen Reduction Systems Market is segmented into type, application, product, end user, regional distribution, and company.

Based on product, automated pathogen reduction systems is expected to dominate the market. Advances in automation technology, such as robotics, machine learning, and AI, have made it possible to develop more sophisticated and efficient automated pathogen reduction systems. Automated systems can be more easily scaled up to accommodate increased production demands, making them suitable for growing businesses. In industries with strict regulatory requirements, automated systems can provide a higher level of control and traceability, making it easier to demonstrate compliance with safety standards.

Based on region, North America segment is expected to grow during the forecast period.  The region has a substantial food processing industry that caters to both domestic and international markets. To meet the demands of these markets and ensure the safety of products, pathogen reduction systems are widely used to mitigate the risk of contamination.  Consumers in North America have high expectations for food quality and safety. As a result, businesses in the food industry are under pressure to implement stringent safety measures, including pathogen reduction, to meet these expectations. The healthcare and pharmaceutical industries in North America also require pathogen reduction systems to ensure the safety of medical equipment, supplies, and products. Sterilization and pathogen reduction are critical in preventing hospital-acquired infections and maintaining the integrity of medical products. North America is often at the forefront of technological advancements. This includes the development of innovative pathogen reduction technologies that cater to the region's high standards for safety and efficiency. North America is a major player in global trade and exports, including food products. To meet international regulations and ensure the acceptance of their products in foreign markets, companies often implement rigorous pathogen reduction measures.

Major companies operating in Global Pathogen Reduction Systems Market are:

          ·         Terumo BCT, Inc.

          ·         Macopharma SA.

          ·         Cerus Corporation.

          ·         AngioDynamics, Inc.

          ·         Octapharma AG.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The increasing prevalence of infectious diseases and growing awareness regarding the necessity of effective blood transfusions serve as significant drivers for the global pathogen reduction system market. Blood transfusion is a fundamental pillar of the modern healthcare system, saving millions of lives annually. However, many hospital patients in low- and middle-income countries lack access to timely and safe blood supply. The risk of pathogen and virus development in blood before transfusion remains significantly high. Nevertheless, the pathogen reduction treatment presents challenges, including the risk of affecting or harming blood cells and the generation of toxic chemical agents. Additionally, fair reimbursement issues pose constraints to the global pathogen reduction system market. Ongoing research and development efforts will play a crucial role in evaluating these new technologies.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York  10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com